Latest Articles

Publication Date
Can Pembrolizumab Improve dMMR Endometrial Cancer Outcomes? - Medscape

Can Pembrolizumab Improve dMMR Endometrial Cancer Outcomes? Medscape

Published: Oct. 28, 2024, 1:14 p.m.
Identification of key genes associated with endometriosis and endometrial cancer by bioinformatics analysis - Frontiers

Identification of key genes associated with endometriosis and endometrial cancer by bioinformatics analysis Frontiers

Published: Oct. 28, 2024, 10:28 a.m.
Endometrial Ablation Equipment Market Overall Study Report - openPR

Endometrial Ablation Equipment Market Overall Study Report openPR

Published: Oct. 28, 2024, 6:27 a.m.
Brachytherapy With Modified Rotte-y Applicator for Inoperable Endometrial Cancer: A Case Report - Cureus

Brachytherapy With Modified Rotte-y Applicator for Inoperable Endometrial Cancer: A Case Report Cureus

Published: Oct. 27, 2024, 7:49 a.m.
Dr. Sharyn Lewin and patient Kristen Foreman talks about endometrial cancer - WTVM

Dr. Sharyn Lewin and patient Kristen Foreman talks about endometrial cancer WTVM

Published: Oct. 24, 2024, 11:32 p.m.
Racial disparities in high-risk endometrial subtype diagnoses reported - Contemporary Obgyn

Racial disparities in high-risk endometrial subtype diagnoses reported Contemporary Obgyn

Published: Oct. 24, 2024, 6:26 p.m.
Neoadjuvant Treatment Considerations for Endometrial Cancer - Cancer Network

Neoadjuvant Treatment Considerations for Endometrial Cancer Cancer Network

Published: Oct. 24, 2024, 6:19 p.m.
Molecular Classification of Endometrial Cancer - Cancer Network

Molecular Classification of Endometrial Cancer Cancer Network

Published: Oct. 24, 2024, 6:19 p.m.
Overview of Endometrial Cancer - Cancer Network

Overview of Endometrial Cancer Cancer Network

Published: Oct. 24, 2024, 6:14 p.m.
Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer - OncLive

Pembrolizumab Earns EU Approval in 2 New Indications for Endometrial and Cervical Cancer OncLive

Published: Oct. 24, 2024, 3:55 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!